Public health activists say unless drug recall policy with legal backing is brought in, guidelines will not serve any purpose; ask who has ultimate authority to verify all batches are recalled.
Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.
Organisation of Pharmaceutical Producers of India seeks nod for drugs to be marketed at same time as US, Europe. But regulator rarely permits a drug launch without local clinical trials.
India's apex drug regulator will form a panel to examine whether more regulatory restrictions should be put in place. Experts say more curbs a good idea but implementation is key.
CDSCO says two cough syrups manufactured by Ankleshwar-based Norris Pharma were found to contain Ethylene Glycol (EG) & Diethylene Glycol (DEG) beyond acceptable limits.
The Central Drugs Standard Control Organisation has formed an inquiry committee following a complaint by ophthalmologist and ex-parliamentarian Dr Vikas Mahatme.
WHO alerted Indian authorities of possible link between the deaths and four cough and cold medicines made by Sonepat-based Maiden Pharmaceuticals on 29 September, it is learnt.
The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.
This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.
We now live in a world order that will keep shifting. India must use this window. This also means we remain disciplined enough not to be knee-jerked into reacting to what Pakistan sees as its moment in the sun.
COMMENTS